Cargando…
Dasatinib Modulates Invasive and Migratory Properties of Canine Osteosarcoma and has Therapeutic Potential in Affected Dogs
BACKGROUND: This investigation sought to elucidate the relationship between hepatocyte growth factor (HGF)–induced metastatic behavior and the tyrosine kinase inhibitors (TKIs) crizotinib and dasatinib in canine osteosarcoma (OS). Preliminary evidence of an apparent clinical benefit from adjuvant th...
Autores principales: | Marley, Kevin, Gullaba, Justine, Seguin, Bernard, Gelberg, Howard B., Helfand, Stuart C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562978/ https://www.ncbi.nlm.nih.gov/pubmed/26310368 http://dx.doi.org/10.1016/j.tranon.2015.03.006 |
Ejemplares similares
-
The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro
por: Marley, Kevin, et al.
Publicado: (2013) -
Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma
por: Marley, Kevin, et al.
Publicado: (2013) -
Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
por: Beck, Olaf, et al.
Publicado: (2020) -
Dasatinib has a dual effect on sepsis
por: Gonçalves-deAlbuquerque, Cassiano F, et al.
Publicado: (2013) -
Canine Soft Tissue Sarcomas: Can Being a Dog’s Best Friend Help a Child?
por: Séguin, Bernard
Publicado: (2017)